Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 1067521생성일: 2026년 10월 24일
Ethyl 2-(6-chloroimidazo[1,2-b]pyridazin-2-yl)-2-methylpropanoate → Ethyl 2-[6-[3-[4-(Diphenylmethoxy)piperidino]-2-hydroxypropylamino]imidazo[1,2-b]pyridazin-2-yl]-2-methylpropionate Difumarate
https://huagongshe.com/ko/reaction/1067521
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Ethyl 2-(6-chloroimidazo[1,2-b]pyridazin-2-yl)-2-methylpropanoate | HCID 11043751 | — |
| 반응물 | Tetrahydrofuran ethyl acetate | HCID 21939870 | — |
| 반응물 | 3-[4-(Diphenylmethoxy)piperidino]-2-hydroxypropylamine | HCID 22989280 | — |
| 생성물 | Ethyl 2-[6-[3-[4-(Diphenylmethoxy)piperidino]-2-hydroxypropylamino]imidazo[1,2-b]pyridazin-2-yl]-2-methylpropionate Difumarate | HCID 69842735 | — |
반응 단계
0.511 g of 3-[4-(diphenylmethoxy)piperidino]-2-hydroxypropylamine and 0.268 g of ethyl 2-[6-chloroimidazo[1,2-b]pyridazin-2-yl]-2-methylpropionate were stirred at 190-200° C. for 3 hours. After cooling, ethyl acetate-tetrahydrofuran (2:1) was added; the mixture was washed with aqueous sodium bicarbonate and saturated saline and dried with magnesium sulfate. The dry product was concentrated under reduced pressure; the residue was subjected to silica gel column chromatography and eluted with ethyl acetate:methanol:triethylamine (90:10:1). The desired fraction was collected, dissolved in 5 ml of ethyl acetate; a solution of 82 mg of fumaric acid in 5 ml of methanol was added, followed by concentration. Ethyl ether was added to the residue; the resulting powder was collected by filtration, washed with ethyl ether and dried to yield 0.223 g of the title compound.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US06248740B1 |
|---|
| 출처 데이터셋 | uspto-grants-2001_06 |
|---|
| ORD ID | ord-8188c6f761d04a45a10c0a0ad446a597 |
|---|
| 출처 메모 | uspto-grants-2001_06 |
|---|